1. Home
  2. GGR vs SERA Comparison

GGR vs SERA Comparison

Compare GGR & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gogoro Inc.

GGR

Gogoro Inc.

HOLD

Current Price

$3.90

Market Cap

83.3M

ML Signal

HOLD

Logo Sera Prognostics Inc.

SERA

Sera Prognostics Inc.

HOLD

Current Price

$1.74

Market Cap

75.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GGR
SERA
Founded
2011
2008
Country
Taiwan
United States
Employees
1416
N/A
Industry
Auto Manufacturing
Precision Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.3M
75.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
GGR
SERA
Price
$3.90
$1.74
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.0K
18.9K
Earning Date
05-21-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
32.32
EPS
N/A
N/A
Revenue
N/A
$81,000.00
Revenue This Year
$5.07
$554.81
Revenue Next Year
N/A
$517.27
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5.19
52 Week Low
$0.24
$1.37
52 Week High
$6.21
$4.09

Technical Indicators

Market Signals
Indicator
GGR
SERA
Relative Strength Index (RSI) 44.08 35.80
Support Level $3.63 N/A
Resistance Level $4.25 $2.41
Average True Range (ATR) 0.20 0.19
MACD -0.05 -0.03
Stochastic Oscillator 25.00 17.39

Price Performance

Historical Comparison
GGR
SERA

About GGR Gogoro Inc.

Gogoro Inc is focused on eliminating the barriers to electric fuel adoption to bring swappable electric power within reach of every urban rider. Its battery swapping technology compromises an interoperable platform that seamlessly integrates a comprehensive ecosystem of hardware, software, and services, which consists of Gogoro Smart Batteries, GoStations, Gogoro Network Software & Battery Management Systems, Smartscooter, and related components and kits. Geographical presence in Taiwan and Other countries, majority of its revenue comes from Tiwan.

About SERA Sera Prognostics Inc.

Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

Share on Social Networks: